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ABSTRACT: Class A β-lactamases cause clinically relevant 
resistance to β-lactam antibiotics. Carbapenem degradation is a 
particular concern. We present an efficient QM/MM molecular 
simulation protocol that accurately predicts the activity of β-
lactamases against carbapenems. Simulations take <24 CPU hours, 
a >99% reduction, and do not require fitting against experimental 
data or significant parameterization. This computational assay also 
reveals mechanistic details of β-lactam breakdown and should 
assist in evaluating emerging β-lactamase variants and developing 
new antibiotics. 
Antibiotic resistance is one of the most concerning phenomena 
of the 21st century.1, 2 To some extent, this resistance occurs 
naturally, but in recent decades its spread has been accelerated by 
the excessive use of antibiotics.3 β-lactam drugs are one of the 
largest groups of commercially available antibiotics and they 
remain the most prescribed ones,4 but they also suffer from 
increasing clinical resistance.5 The most important causes for this 
resistance, especially in Gram-negative bacteria, are the β-
lactamase enzymes.6-8
β-lactamases can be divided into four different classes based on 
their primary amino acid sequence homology (Ambler 
classification): classes A, C, and D are serine β-lactamases with an 
active site serine residue, whilst class B are metallo-β-lactamases 
with active site zinc ion(s).9 Of the four classes class A β-
lactamases are the largest, with many clinically significant 
enzymes. They can inactivate a broad range of β-lactam substrates: 
in addition to hydrolyzing penicillins and cephalosporins, some 
family members can also mediate resistance against 
carbapenems.10-12 Carbapenems are mainly used as ‘last resort’ 
antibiotics or for difficult infections,13 hence the Centers for 
Disease Control and Prevention (CDC) have categorized the 
clinical importance of carbapenemase-producing 
Enterobacteriaceae (the group of Gram-negative bacteria including 
Escherichia coli and Klebsiella pneumoniae) as “an immediate 
public health threat that requires urgent and aggressive action”.14
β-lactamases inactivate β-lactam antibiotics by hydrolyzing the 
β-lactam amide (Figure 1). In serine β-lactamases, this consists of 
two consecutive reactions: acylation, resulting in formation of a 
covalently-bound acylenzyme, and deacylation.8 In acylation, a 
nucleophilic attack by the active site serine upon the -lactam 
carbonyl carbon occurs to form the acylenzyme, via a tetrahedral 
intermediate.15 Deacylation is analogous to acylation including a 
tetrahedral intermediate (TI), but the nucleophile is an active site 
water molecule (the deacylating water, DW). In class A enzymes, 
both nucleophiles are activated via proton abstraction by an active 
site glutamate residue (Glu166 in the class A β-lactamase 
numbering scheme).16, 17 β-lactamases are typically inhibited when 
the acylenzyme intermediate is long-lived due to slow deacylation 
rates.18 For many β-lactam:β-lactamase combinations, in particular 
reactions involving carbapenems, TI formation in deacylation of 
the acylenzyme is probably the rate-limiting step.13 Therefore, to 
determine the carbapenemase activity of class A β-lactamases, only 
this reaction needs to be modelled.
Previously, a quantum mechanics/molecular mechanics 
(QM/MM) protocol for modelling TI formation in the deacylation 
step for class A enzymes with meropenem was shown to correctly 
distinguish between carbapenemases and non-carbapenemases.18 
Using the proposed protocol, carbapenem-inhibited enzymes 
showed deacylation barriers of 17.0-18.9 kcal/mol, whilst for 
carbapenem-hydrolyzing enzymes the values were 7.5-10.5 
kcal/mol. A similar computational protocol has been used to study 
class A β-lactamase inhibition by clavulanate, which identified the 
covalent clavulanate complex responsible for irreversible β-
lactamase inhibition.19 Being based on QM methods and standard 
force fields, no additional parameterization is required for their 
application. Despite the promising results of these protocols, the 
carbapenem assay requires significant computational resources due 
to extensive sampling of the free energy surface. Hence, it cannot 
be used for more rapid, computationally efficient, screening of a 
variety of different enzyme-antibiotic combinations. 
Starting from our previous work, here we present and validate a 
more rapid computational assay that can discriminate between 
carbapenemase activities using only limited computational 
resources. The resources are minimized first by limiting the area on 
the free energy surfaces (FES) to be sampled, and then by reducing 
the sampling time. We demonstrate that this reduced protocol, 
requiring less than 1 % of the computational resources of the 
Page 1 of 8
ACS Paragon Plus Environment






























































original assay, can still correctly distinguish between 
carbapenemases and carbapenem-inhibited class A β-lactamases. It 
therefore provides an efficient computational diagnostic towards in 
silico screening of β-lactamase activity.
Figure 1. A) First step of deacylation in class A β-lactamases. 
Glu166 acts as a proton acceptor allowing the deacylating water to 
perform nucleophilic attack on the acylenzyme, which results in 
tetrahedral intermediate formation. B) Full free energy surface of 
deacylation for KPC-2 with meropenem. Red circles show the 
positions of umbrella sampling windows along the approximate 
“standard” minimum free energy path (MFEP) used for all 
enzymes. AC = acylenzyme, TS = approximate transition state, TI 
= tetrahedral intermediate. C) Active site of KPC-2 highlighting the 
hydrogen bonds between Glu-166 OΕ1 and OΕ2 and relevant 
residues. Meropenem in magenta.  
We investigate eight class A -lactamases, including the widely 
distributed K. pneumoniae carbapenemase (KPC), and the TEM, 
SHV and CTX-M enzymes (Table 1), selected for their clinical 
relevance and their ability (or inability) to hydrolyse carbapenems. 
Acylenzyme systems were prepared as described previously 
(details in ESI).18 Briefly, structures were solvated in water and 
minimized, followed by heating to 300 K in 50 ps. Starting 
structures for umbrella sampling (US) were then taken after at least 
50 ps of unrestrained QM/MM MD (with starting points for repeat 
simulations at least 15 ps apart). Two reaction coordinates are used 
for umbrella sampling: one for the proton transfer between DW and 
Glu166, and one the nucleophilic attack of DW on the acylenzyme 
carbonyl. The DFTB2 (SCC-DFTB) method was used for the QM 
region.20 All calculations were performed with sander from 
AmberTools16.21 The weighted-histogram analysis method 
(WHAM)22 was used to analyze US results and to obtain calculated 
barriers for each reaction (Δ‡Gcalc). Three independent US 
simulations were run for each acylenzyme to test convergence of 
Δ‡Gcalc (details in the ESI; meropenem parameters at DOI 
10.6084/m9.figshare.8158097).
Several modifications to the protocol were evaluated in order to 
improve computational efficiency. First, the amount of sampling 
was reduced by sampling only at those US windows corresponding 
to the approximate minimum free energy path (MFEP) on the FES. 
Based on our earlier work,18 the calculated MFEPs on full FESs 
across all eight studied β-lactamases are similar, which implies that 
only a partial FES needs to be calculated to compare the 
deacylation rates between studied enzymes. The “standard” MFEP 
used for partial sampling along the FES is presented in Figure 1 
(and in the ESI). Sampling only in windows along this MFEP 
reduces the amount of US calculations from the original 374 to 28 
per (partial) surface. The more limited sampling along the surface 
does not change the resulting Δ‡Gcalc values significantly (which 
are underestimated at this QM level, as expected18), with the largest 
calculated change between full and partial surface calculations 
being 2.5 kcal/mol (Table 1). Despite some changes in Δ‡Gcalc 
values for all enzymes, the correct division into two groups is 
maintained. Carbapenemases (KPC, SFC, SME and NMC) have 
Δ‡Gcalc values between 7.8-10.4 kcal/mol, and carbapenem-
inhibited enzymes (SHV, TEM, BlaC and CTX-M) between 15.5-
16.8 kcal/mol. This suggests that the standard MFEP describes 
deacylation sufficiently well for differentiating between different 
carbapenem-hydrolyzing abilities. 
Even when the amount of US windows is significantly reduced, 
the computational time for each window remains high. Hence, the 
possibility of utilizing shorter sampling times was first tested using 
the original 20 ps US results. This was done by using only the first 
0.5, 1, 2, 5 or 10 ps of each 20 ps US window to calculate Δ‡Gcalc 
values (Table S2). This differs from sampling each window for a 
shorter time only, since the system is still allowed to equilibrate for 
20 ps before changing the reaction coordinate restraints. 
Nonetheless, this preliminary analysis can be used to study the 
effects of shorter sampling. The results indicate that sampling for 
only a fraction of 20 ps is enough to distinguish between the two 
groups of β-lactamases. In most cases, the preliminary shorter 
sampling times yield somewhat higher barriers (<2.5 kcal/mol), 
which is expected due to reduced sampling of the phase space. 
However, this does not affect the distinction between 
carbapenemases and non-carbapenemases.  When reducing 
sampling to 1 ps per window or less, more significant increases of 
the barrier heights (up to 20%) become common. We thus decided 
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to use 2 ps US sampling per window. Sampling for 2 ps also ensures 
enough overlap between sampling in adjacent US windows.  
Table 1. Comparison of experimental (Δ‡Gexp) and calculated free energies of activation (Δ‡Gcalc) for the first step of 
deacylation of meropenem by eight enzymes using different protocols. 
Δ‡Gcalc (kcal/mol) c
β-lactamase kcat (s–1) a
Δ‡Gexp 
(kcal/mol) b Full a MFEP (20ps) MFEP (2ps)
KPC-2 3.6 16.8 10.5 (0.9) 8.5 (2.2) 9.1 (1.1)
SFC-1 6.5 16.6 10.9 (0.9) 10.4 (1.2) 9.9 (1.3)
SME-1 3.2 16.9 10.3 (2.8) 7.8 (0.2) 9.5 (1.4)
NMC-A 12.0 16.1 7.5 (0.4) 8.8 (0.4) 10.4 (0.7)
SHV-1 0.0013 21.6 17.0 (0.4) 16.1 (1.0) 19.5 (0.5)
TEM-1 0.0023 22.7 17.1 (0.4) 16.3 (2.2) 23.6 (1.4)
BlaC 0.0017 21.5 17.9 (0.1) 15.5 (2.2) 24.7 (1.1)
CTX-M-16 0.0042 20.8 18.9 (1.1) 16.8 (1.5) 17.2 (1.6)
Computer resource (%) d 100 7.5 0.75
a) Values taken from ref. 19. b) Calculated from experimental rate constants using the Eyring equation, see ref. 19. c) Barriers are calculated 
from three simulations using WHAM as described in the ESI, standard deviations in parenthesis. d) Computer resources required are 
estimated by extrapolating the time needed for all required QM/MM (DFTB2/ff12SB) simulations from 2 ps calculations: 374 umbrella 
sampling windows for the whole surface and 20 ps per window (374 x 20) for “Full”, 28 windows x 20 ps for “MFEP (20ps)” and 28 
windows x 2 ps for “MFEP (2ps)”.
Sampling for only 2 ps per window along the MFEP gives 
similar overall results to sampling for 20 ps (Table 1). With the 
shorter protocol, carbapenemases have Δ‡Gcalc values of 9.1-10.4 
kcal/mol, whilst carbapenem-inhibited enzymes have Δ‡Gcalc 
values of 17.2-24.7 kcal/mol. Shorter US gives higher deacylation 
Δ‡Gcalc values for all enzymes when compared to calculations using 
20 ps sampling along the MFEP, with most significant increases 
seen for carbapenem-inhibited enzymes (0.4-9.2 kcal/mol). 
However, the increased deacylation barriers do not change the 
division of the enzymes into the two distinct groups. Furthermore, 
the shortened protocol (see ESI for details) enables running 
calculations on modest computing resources (e.g. on a desktop with 
one CPU) in a reasonable time. For the largest system (SFC-1, 
containing 54.9k atoms), US takes on average 23 hours to finish on 
one 2.6 GHz CPU. In general, the more efficient assay requires less 
than 1 % of the computer resources needed for the original assay 
(Table 1). 
The efficient assay we have developed can be used to study 
specific mechanistic details of carbapenem hydrolysis. Glu166, the 
general base in deacylation, has two chemically inequivalent 
carboxylate oxygens: one that forms a hydrogen bond with Asn170 
(OΕ1), and one that interacts with Lys73 (OΕ2) (Figure 1C). The 
DW hydrogen bonds with OΕ2 in all MD simulations, and the US 
calculations have been performed using this oxygen as the proton 
acceptor. However, proton transfer to OΕ1 might also be relevant 
for deacylation. We thus used our new, efficient protocol to 
compare the two possible proton acceptors. When forcing the 
proton transfer to OΕ1, the Δ‡Gcalc values increase by >3 kcal/mol 
for the carbapenemases (Table S3). Significant increases also incur 
for the carbapenem-inhibited enzymes (especially if the barrier 
with proton transfer to OΕ2 was not very high already). This 
consistent increase implies that the most probable proton transfer 
pathway in carbapenem hydrolysis is via Glu166:OΕ2 that interacts 
with Lys73, thus indicating an important role for this residue. 
Preference for one carboxylate oxygen (where the two oxygens 
have different hydrogen bonding environments) as the general base 
has been observed also in other enzymes.23 For the β-lactamases 
here, the DW is primarily hydrogen bonded with OE2 in the 
acylenzyme MD simulations and this interaction is thus present in 
all starting structures for US calculations. The preference for OE2 
acting as the base can be explained by inspecting the additional 
hydrogen bonds formed by the Lys73 and Asn170 side chains. 
Lys73 interacts with Glu166:OΕ2 as well as Asn132, Ser70, 
meropenem and the Ser130 backbone carbonyl oxygen, whilst 
Asn170 interacts only with Glu166:OΕ1 and the backbone 
carbonyl of Leu167. Upon a proton transfer, other residues can 
balance the weakening interaction of Lys73 with Glu166:OΕ2, 
whereas Asn170 has fewer other interactions for such stabilization.
In conclusion, the carbapenemase activity of eight class A β-
lactamases was assayed in silico using QM/MM reaction 
simulations with an optimized, efficient computational protocol. 
Assays based on computational biomolecular simulation are 
increasingly common and can complement traditional experimental 
assays.24  Assay efficiency is achieved here by using the semi-
empirical DFTB2 method and by limiting both conformational 
space and time sampled. Distinction between four enzymes known 
to efficiently hydrolyse carbapenems, and four enzymes that do not, 
can be made within a day with very modest computer resources 
(e.g. one CPU per enzyme). Additionally, this efficient assay can 
be used to inspect mechanistic aspects of carbapenem inactivation; 
exemplified here by comparing the Δ‡Gcalc values of the first 
deacylation step for two possible proton transfer pathways. The 
short computational assay time with moderate computer resources 
now makes this assay attractive for more rapid in silico activity 
screening of different class A β-lactamase – antibiotic 
combinations. This will assist assessment and understanding of 
resistance to β-lactam drugs as conferred by β-lactamases, e.g. the 
effect of acquired point mutations on drug hydrolysis. As access to 
genome sequences of pathogen isolates becomes more routine, 
such information could be used in guiding prescription decisions. 
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Furthermore, elucidation of mechanistic details of acyl-enzyme 
hydrolysis, as identified in simulations, may guide the development 
of new β-lactams or β-lactamase inhibitors designed to evade the 
activity of broad-spectrum and carbapenem-hydrolyzing -
lactamases.
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Figure 1. A) First step of deacylation in class A β-lactamases. Glu166 acts as a proton acceptor allowing the 
deacylating water to perform nucleophilic attack on the acylenzyme, which results in tetrahedral 
intermediate formation. B) Full free ener-gy surface of deacylation for KPC-2 with meropenem. Red circles 
show the positions of umbrella sampling windows along the approximate “standard” minimum free energy 
path (MFEP) used for all enzymes. AC = acylenzyme, TS = approx-imate transition state, TI = tetrahedral 
intermediate. C) Active site of KPC-2 highlighting the hydrogen bonds between Glu-166 OΕ1 and OΕ2 and 
relevant residues. Meropenem in magenta. 
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